Department of Nuclear Medicine

Matthias Eiber
- Department of Nuclear Medicine
Person
20072026
Christian Lohrmann
- Department of Nuclear Medicine
Person
20022026
Stephan Nekolla
- Department of Nuclear Medicine
Person
19922026

1 Active

T-RAFIC: Training network for tracking and controlling therapeutic immune cells in cancer
Kobold, S. (Spokesperson) & Weber, W. (PI)
1/04/25 → 31/03/29
Project: Research

[¹⁸F]Flotufolastat PET/MRI in Patients with Suspected Prostate Cancer: Correlation with Histopathologic Biopsy Results
Gabler, N., Kirchhoff, S., Sauter, A., Heck, M., Lorenzini, T., Haller, B., Weber, W. A., Eiber, M. & Rauscher, I., Feb 2026, In: Journal of Nuclear Medicine. 67, 2, p. 217-223 7 p.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
¹⁷⁷Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial
PSMAddition Investigators, 29 Aug 2026, In: The Lancet. 408, 10557, p. 793-807 15 p.
Research output: Contribution to journal › Article › peer-review
¹⁷⁷Lu-PSMA-617 SPECT/CT for Early Prediction of Overall Survival in Participants with Metastatic Castration-Resistant Prostate Cancer
Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Apr 2026, In: Radiology. 319, 1, e252672.
Research output: Contribution to journal › Article › peer-review
2 Scopus citations